PMID: 34668923
Title: Days at Home After Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients.

Abstract: This comparative effectiveness research study uses Medicare claims data to examine the total number of days at home among intermediate-risk patients recovering from transcatheter aortic valve replacement (TAVR) vs patients recovering from surgical aortic valve replacement (SAVR).

Citation: Chung M, et al. Days at Home After Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients. Days at Home After Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients. 2022; 7:110-112. doi: 10.1001/jamacardio.2021.4036

Link: https://pubmed.ncbi.nlm.nih.gov/34668923/
